daily replenisher mixed berry glp-1 support Replenza 6.8 oz EXP 9/2026 Real results, real insight! 💙

PlexusDx supports precision-wellness conversations by connecting genetic insights with clinical dosing frameworks

Emerging evidence even suggests these medications may positively influence energy expenditure and overall metabolic health, although research in this area is still ongoing

For liver health, a Phase 2a trial in patients with metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as NAFLD) showed extraordinary results

Key findings: Prescribing trends Using a subset of Truveta Data, Truveta Research identified people who were prescribed a GLP-1 RA between January 01, 2019 and December 31, 2025